KOVAIKovai Medical Center & Hospital Ltd.
Kovai Medical Center & Hospital Q2 FY27 Results: Standalone Net Profit ₹76.97 Crore on Total Income of ₹481 Crore
- Earnings
- hospitals

Kovai Medical Center & Hospital (NSE: KOVAI) reported total income of ₹480.73 crore and net profit of ₹76.97 crore for the quarter ended 30 Sep 2026, it said in a filing on 11 Nov 2026. The company has no subsidiary, associate or joint venture, so only standalone results were reported.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹480.73 crore, up 20.7% YoY and 9.6% QoQ
- Net profit: ₹76.97 crore, up 30.8% YoY and 11.4% QoQ
- EPS: ₹70.34 basic and diluted, against ₹53.79 a year earlier
- Finance costs: ₹7.84 crore, down 10.3% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 480.73 | 398.40 | +20.7% | 438.65 | +9.6% | |
| Revenue from operations | 472.21 | 390.74 | +20.9% | 430.91 | +9.6% |
| Other income | 8.10 | 7.31 | +10.8% | 7.34 | +10.3% |
| 76.97 | 58.86 | +30.8% | 69.09 | +11.4% | |
| Profit before tax | 103.75 | 77.89 | +33.2% | 91.54 | +13.3% |
| Finance costs | 7.84 | 8.74 | -10.3% | 8.02 | -2.2% |
| Depreciation | 33.42 | 26.78 | +24.8% | 31.73 | +5.3% |
| Tax expense | 26.79 | 19.03 | +40.8% | 22.45 | +19.3% |
| Net profit margin | 16.01% | 14.77% | +1.24 pp | 15.75% | +0.26 pp |
| EPS, basic (₹) | 70.34 | 53.79 | +30.8% | 63.14 | +11.4% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit rose 30.8% YoY against 20.7% growth in total income, and profit before tax rose 33.2%. Finance costs fell to ₹7.84 crore from ₹8.74 crore a year earlier, which is 1.6% of total income this quarter.
Other income is a small part of the result. At ₹8.10 crore it is 1.7% of total income and 7.8% of profit before tax of ₹103.75 crore. Revenue from operations, at ₹472.21 crore, rose 20.9% YoY, so most of the growth is from operations.
Tax took a larger share of profit this quarter. The tax expense of ₹26.79 crore is 25.8% of profit before tax, up from 24.4% a year earlier. The filing's notes do not give a reason for the rise in deferred tax, which the statement shows as ₹2.13 crore against a credit in the year-earlier quarter.
Depreciation rose 24.8% YoY to ₹33.42 crore, and employee benefits and consulting charges also rose in the quarter. The filing does not give a reason for these increases.
The filing's notes disclose an adjudication order dated 27 Oct 2026 from the Joint Commissioner of Customs (Air Cargo), Chennai, in a matter over machinery imported in 1988 that was previously disclosed as a contingent liability. The order determines an amount of ₹2.11 crore payable with applicable interest, which the company estimates at around ₹10 crore.
The company says it is evaluating the order to decide its future course of action. No provision has been made in the books of accounts for the quarter.
Inference
The filing reports ₹16.26 crore of dividends paid in the half year ended 30 Sep 2026, against ₹10.82 crore a year earlier. The Customs order is the one contingent matter the notes describe, and the filing does not say what the company will do with it or whether a provision will follow.
The filing does not state the reason for the sharp rise in tax or for the rise in employee and consulting costs, and it does not say how the Customs matter will be resolved.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

